GRF One Health Summit 2012, Davos: Presentation by Francisco.REVIRIEGO, Policy Officer - Legislative veterinary officer - Head of Sector, Animal health, EU
Sustainable Agricultural Development for Food Security and Nutrition: What Ro...SIANI
A report by the CFS High Level Panel of Experts on Food Security and Nutrition. Presented by Delia Grace at the seminar "Antimicrobial resistance; linkages between humans, livestock and water in peri-urban areas" at the World Water Week, 29th August 2016.
3rd GRF One Health Summit 2015
Keynote V: AMR – There is a lot going on, but not enough One Health
Peter BORRIELLO, Professor, Chief Executive Officer, Veterinary Medicines Directorate VMD, Surrey, United Kingdom
Antimicrobial Resistance and the Governance of Water Resources in South AfricaSIANI
Presented by Stanley Liphadzi & Jay Bhagwan at the Seminar "Antimicrobial resistance; linkages between humans, livestock and water in periurban areas", as part of the World Water Week, 29th August 2016.
Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...Fundación Ramón Areces
El martes 5 de junio del 2018 organizamos una Jornada en la Fundación Ramón Areces, en la cual se habló sobre el consumo de antibióticos y transmisión de resistencia entre humanos y animales.
Sustainable Agricultural Development for Food Security and Nutrition: What Ro...SIANI
A report by the CFS High Level Panel of Experts on Food Security and Nutrition. Presented by Delia Grace at the seminar "Antimicrobial resistance; linkages between humans, livestock and water in peri-urban areas" at the World Water Week, 29th August 2016.
3rd GRF One Health Summit 2015
Keynote V: AMR – There is a lot going on, but not enough One Health
Peter BORRIELLO, Professor, Chief Executive Officer, Veterinary Medicines Directorate VMD, Surrey, United Kingdom
Antimicrobial Resistance and the Governance of Water Resources in South AfricaSIANI
Presented by Stanley Liphadzi & Jay Bhagwan at the Seminar "Antimicrobial resistance; linkages between humans, livestock and water in periurban areas", as part of the World Water Week, 29th August 2016.
Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...Fundación Ramón Areces
El martes 5 de junio del 2018 organizamos una Jornada en la Fundación Ramón Areces, en la cual se habló sobre el consumo de antibióticos y transmisión de resistencia entre humanos y animales.
Dominique L. Monnet Director del programa ARHAI (Antimicrobial Resistance an...Fundación Ramón Areces
El martes 5 de junio del 2018 organizamos una Jornada en la Fundación Ramón Areces, en la cual se habló sobre el consumo de antibióticos y transmisión de resistencia entre humanos y animales.
“EFSA lacks autonomy, it is subject to the lobbies.
Its mode of operation must be revised from top to bottom.”
JOSÉ BOVÉ
http://elproyectomatriz.wordpress.com/2011/06/14/efsa-agencia-europea-de-seguridad-alimentaria-%c2%bfseguridad/
Overview of Laws Regulating Antibiotics in Livestock & Policy Positions of St...Cari Rincker
This was prepared for a presentation for the Association for the Bar for the City of New York's Committee on Animal Law & Health Law Committee. Outline with more detail and citations is available at http://www.jdsupra.com/legalnews/overviews-of-laws-regulating-antibiotics-15572/.
The relevance of the farming community regarding zoonosesHarm Kiezebrink
During the EFSA’s Stakeholder Consultative meeting in Parma on Wednesday 29th and Thursday 30th June 2011, EFS interacted with the stakeholders on EFSA’s scientific activities and the outlook of the future activities involving the stakeholders. During the meeting Annette TOFT presented the opinion of the European farmers and agricultural cooperatives COPA – COGECA stressing the relevance of zoonoses questions to farmers and agri - cooperatives activities.
Presenter: Chris Thornton
European Sustainable Phosphorus Platform (ESPP)
www.phosphorusplatform.eu
Sustainable management of nutrients is crucial for agriculture, food, industry, water and the environment. ESPP brings together companies and stakeholders to address the Phosphorus Challenge and its opportunities for the circular economy.
Countries:
Austria AT
Belgium BE
Bulgaria BG
Cyprus CY
Czech Republic CZ
Germany DE
Denmark DK
Estonia EE
Spain ES
Finland FI
France FR
Greece EL
Hungary HU
Ireland IE
Italy IT
Lithuania LT
Luxembourg LU
Latvia LV
Malta MT
Netherlands NL
Poland PL
Portugal PT
Romania RO
Sweden SE
Slovenia SI
Slovakia SK
United Kingdom UK
Switzerland CH
Phosphorus:
Fosfor
Fosfor
Fòsfòr
Фосфор
Fosfor
Фосфор
Fosfor
Fosfor
Фосфор
Фосфор
Fosforas
Fosfors
Fuosfuors
Fosfor
Ffуsfforws
Fosfar
Fosfaras
Fosfaar
Fosforus
Φωσφορος
Ֆոսֆոր
Fosfor
Fosfor
Фосфор
Фосфор
ফসফরাস
فسفر
ફૉસ્ફરસનો
फास्फोरस
Fosfor
Fosfori
Foszfor
Фосфор
Фосфор
Паликандур
Fosfor
Fosfor
Фосфор
Фосфор
Фосфор
Фосфор
Fosfor
فوسفور
Fosfor
Fosforoa
ფოსფორი
[fūsfūr]
זרחן
Fosfru
Lìn
リン
인
ฟอสฟอรัส
Photpho
磷
Posporo
Fosfor
Pūtūtae-whetū
Fosforus
ഫോസ്ഫറസ്
பொஸ்பரசு
Fosofo
Fosforase
Posfori
Fósforo
Phusphuru
Fosforimi
Fosforo
Fosforon
Pesticium
Dr. Tom Chiller - International Activities in Antimicrobial ResistanceJohn Blue
International Activities in Antimicrobial Resistance - Dr. Tom Chiller, Associate Director for Epidemiologic Science, Division of Foodborne, Waterborne, and Environmental Diseases, US Centers for Disease Control and Prevention, from the 2014 NIAA Symposium on Antibiotics Use and Resistance: Moving Forward Through Shared Stewardship, November 12-14, 2014, Atlanta, Georgia, USA.
More presentations at http://www.swinecast.com/2014-niaa-antibiotics-moving-forward-through-shared-stewardship
Roundtable of aflatoxin experts on
“Building a multi-stakeholder approach to mitigate aflatoxin contamination of food and feed”
Brussels, Monday 25th January 2016
Low use of antimicrobials and healthy productive animals – a possible equation?SIANI
Presentation by Professor Ulf Magnusson, Swedish University of Agricultural Sciences/ SLU Global at the event: Low use of antimicrobials and healthy productive animals – a possible equation? At FAO Headquarters in Rome, Italy 19th of October, 2016.
Dr. Paul Ruen - The future of Antibiotic Use: Are you, your feed mill and vet...John Blue
The future of Antibiotic Use: Are you, your feed mill and veterinarian ready for January 1, 2017? How did we get here? What does it mean? - Dr. Paul Ruen, Fairmont Veterinary Clinic, from the 2016 Minnesota Pork Congress, January 18 - 20, 2016, Minneapolis, MN, USA.
More presentations at http://www.swinecast.com/2016-minnesota-pork-congress
Dr. Bill Pomputius - Antimicrobial Resistance in Human Medicine - Impact and ...John Blue
Antimicrobial Resistance in Human Medicine - Impact and Stewardship - Dr. Bill Pomputius, from the 2018 Allen D. Leman Swine Conference, September 15-18, 2018, St. Paul, Minnesota, USA.
More presentations at http://www.swinecast.com/2018-leman-swine-conference-material
Assessing antimicrobial resistance and antibiotic use in agricultural food sy...ILRI
Presentation by Hung Nguyen-Viet, Pham Duc Phuc, Dang Xuan Sinh and Do Van Hoan at a workshop on "Intensifying food systems and health: Emphasis on antimicrobial use in agricultural systems", Jaipur, India, 4–6 April 2018.
The Austrian Agency for Health and Food Safety (AGES) is a government owned agency attached to the Federal Ministry for Health and to the Federal Ministry of Agriculture, Forestry, Environment and Water Management. AGES was established on the basis of a Federal law as a private entity (limited company) with a public service mission.
The business areas of AGES are Food Security, Food Safety, Animal health, Public Health, Medicines and Medical Devices, Radiation Protection, Statistics and Risk Assessment and Research and Capacity Building. AGES is responsible for food from soil to fork, effective control and prevention of epidemics for people, animals and plants and providing effective and safe pharmaceutical products.
AGES executes federal state tasks in the areas conducts research in the areas above mentioned. AGES is recognized as "research" and "non-profit" organization according to FP7 rules for participation.
AGES operates the federal laboratories related to food and feed safety, water analysis and radiation protection, the main diagnostic laboratories related to food safety and human health, animal health and plant health. AGES’s laboratories serve as national reference laboratories according to Regulation No. (EC) 882/2004, as national reference laboratories for animal diseases (OIE), as reference center’s for infectious diseases and as official laboratories for plant health, seeds and propagating material.
AGES employs approximately 1.350 persons, of whom more than 40% are scientists or experts with academic degrees (approx. 300 PhDs and 15 university professors) in nearly all disciplines related to food and health safety.
Contact:
DI. Mag. DDr. Alois Leidwein
Tel.: +43 (0)50 555 – 34853
E-Mail: alois.leidwein@ages.at
Homepage: http://www.ages.at/ages/en/research-international-cooperation/
NRDC ISSUe brIeF
Playing Chicken with Antibiotics:
Previously Undisclosed FDA Documents Show Antibiotic Feed Additives Don’t Meet the Agency’s Own Safety Standards
Dominique L. Monnet Director del programa ARHAI (Antimicrobial Resistance an...Fundación Ramón Areces
El martes 5 de junio del 2018 organizamos una Jornada en la Fundación Ramón Areces, en la cual se habló sobre el consumo de antibióticos y transmisión de resistencia entre humanos y animales.
“EFSA lacks autonomy, it is subject to the lobbies.
Its mode of operation must be revised from top to bottom.”
JOSÉ BOVÉ
http://elproyectomatriz.wordpress.com/2011/06/14/efsa-agencia-europea-de-seguridad-alimentaria-%c2%bfseguridad/
Overview of Laws Regulating Antibiotics in Livestock & Policy Positions of St...Cari Rincker
This was prepared for a presentation for the Association for the Bar for the City of New York's Committee on Animal Law & Health Law Committee. Outline with more detail and citations is available at http://www.jdsupra.com/legalnews/overviews-of-laws-regulating-antibiotics-15572/.
The relevance of the farming community regarding zoonosesHarm Kiezebrink
During the EFSA’s Stakeholder Consultative meeting in Parma on Wednesday 29th and Thursday 30th June 2011, EFS interacted with the stakeholders on EFSA’s scientific activities and the outlook of the future activities involving the stakeholders. During the meeting Annette TOFT presented the opinion of the European farmers and agricultural cooperatives COPA – COGECA stressing the relevance of zoonoses questions to farmers and agri - cooperatives activities.
Presenter: Chris Thornton
European Sustainable Phosphorus Platform (ESPP)
www.phosphorusplatform.eu
Sustainable management of nutrients is crucial for agriculture, food, industry, water and the environment. ESPP brings together companies and stakeholders to address the Phosphorus Challenge and its opportunities for the circular economy.
Countries:
Austria AT
Belgium BE
Bulgaria BG
Cyprus CY
Czech Republic CZ
Germany DE
Denmark DK
Estonia EE
Spain ES
Finland FI
France FR
Greece EL
Hungary HU
Ireland IE
Italy IT
Lithuania LT
Luxembourg LU
Latvia LV
Malta MT
Netherlands NL
Poland PL
Portugal PT
Romania RO
Sweden SE
Slovenia SI
Slovakia SK
United Kingdom UK
Switzerland CH
Phosphorus:
Fosfor
Fosfor
Fòsfòr
Фосфор
Fosfor
Фосфор
Fosfor
Fosfor
Фосфор
Фосфор
Fosforas
Fosfors
Fuosfuors
Fosfor
Ffуsfforws
Fosfar
Fosfaras
Fosfaar
Fosforus
Φωσφορος
Ֆոսֆոր
Fosfor
Fosfor
Фосфор
Фосфор
ফসফরাস
فسفر
ફૉસ્ફરસનો
फास्फोरस
Fosfor
Fosfori
Foszfor
Фосфор
Фосфор
Паликандур
Fosfor
Fosfor
Фосфор
Фосфор
Фосфор
Фосфор
Fosfor
فوسفور
Fosfor
Fosforoa
ფოსფორი
[fūsfūr]
זרחן
Fosfru
Lìn
リン
인
ฟอสฟอรัส
Photpho
磷
Posporo
Fosfor
Pūtūtae-whetū
Fosforus
ഫോസ്ഫറസ്
பொஸ்பரசு
Fosofo
Fosforase
Posfori
Fósforo
Phusphuru
Fosforimi
Fosforo
Fosforon
Pesticium
Dr. Tom Chiller - International Activities in Antimicrobial ResistanceJohn Blue
International Activities in Antimicrobial Resistance - Dr. Tom Chiller, Associate Director for Epidemiologic Science, Division of Foodborne, Waterborne, and Environmental Diseases, US Centers for Disease Control and Prevention, from the 2014 NIAA Symposium on Antibiotics Use and Resistance: Moving Forward Through Shared Stewardship, November 12-14, 2014, Atlanta, Georgia, USA.
More presentations at http://www.swinecast.com/2014-niaa-antibiotics-moving-forward-through-shared-stewardship
Roundtable of aflatoxin experts on
“Building a multi-stakeholder approach to mitigate aflatoxin contamination of food and feed”
Brussels, Monday 25th January 2016
Low use of antimicrobials and healthy productive animals – a possible equation?SIANI
Presentation by Professor Ulf Magnusson, Swedish University of Agricultural Sciences/ SLU Global at the event: Low use of antimicrobials and healthy productive animals – a possible equation? At FAO Headquarters in Rome, Italy 19th of October, 2016.
Dr. Paul Ruen - The future of Antibiotic Use: Are you, your feed mill and vet...John Blue
The future of Antibiotic Use: Are you, your feed mill and veterinarian ready for January 1, 2017? How did we get here? What does it mean? - Dr. Paul Ruen, Fairmont Veterinary Clinic, from the 2016 Minnesota Pork Congress, January 18 - 20, 2016, Minneapolis, MN, USA.
More presentations at http://www.swinecast.com/2016-minnesota-pork-congress
Dr. Bill Pomputius - Antimicrobial Resistance in Human Medicine - Impact and ...John Blue
Antimicrobial Resistance in Human Medicine - Impact and Stewardship - Dr. Bill Pomputius, from the 2018 Allen D. Leman Swine Conference, September 15-18, 2018, St. Paul, Minnesota, USA.
More presentations at http://www.swinecast.com/2018-leman-swine-conference-material
Assessing antimicrobial resistance and antibiotic use in agricultural food sy...ILRI
Presentation by Hung Nguyen-Viet, Pham Duc Phuc, Dang Xuan Sinh and Do Van Hoan at a workshop on "Intensifying food systems and health: Emphasis on antimicrobial use in agricultural systems", Jaipur, India, 4–6 April 2018.
The Austrian Agency for Health and Food Safety (AGES) is a government owned agency attached to the Federal Ministry for Health and to the Federal Ministry of Agriculture, Forestry, Environment and Water Management. AGES was established on the basis of a Federal law as a private entity (limited company) with a public service mission.
The business areas of AGES are Food Security, Food Safety, Animal health, Public Health, Medicines and Medical Devices, Radiation Protection, Statistics and Risk Assessment and Research and Capacity Building. AGES is responsible for food from soil to fork, effective control and prevention of epidemics for people, animals and plants and providing effective and safe pharmaceutical products.
AGES executes federal state tasks in the areas conducts research in the areas above mentioned. AGES is recognized as "research" and "non-profit" organization according to FP7 rules for participation.
AGES operates the federal laboratories related to food and feed safety, water analysis and radiation protection, the main diagnostic laboratories related to food safety and human health, animal health and plant health. AGES’s laboratories serve as national reference laboratories according to Regulation No. (EC) 882/2004, as national reference laboratories for animal diseases (OIE), as reference center’s for infectious diseases and as official laboratories for plant health, seeds and propagating material.
AGES employs approximately 1.350 persons, of whom more than 40% are scientists or experts with academic degrees (approx. 300 PhDs and 15 university professors) in nearly all disciplines related to food and health safety.
Contact:
DI. Mag. DDr. Alois Leidwein
Tel.: +43 (0)50 555 – 34853
E-Mail: alois.leidwein@ages.at
Homepage: http://www.ages.at/ages/en/research-international-cooperation/
NRDC ISSUe brIeF
Playing Chicken with Antibiotics:
Previously Undisclosed FDA Documents Show Antibiotic Feed Additives Don’t Meet the Agency’s Own Safety Standards
Healthcare and medicine are being revolutionized by communications and computational resources. Understanding how the convergence of these enabling technologies is advancing our ability to get and stay well is the topic of this presentation.
“Biomedical engineering is a discipline that
advances knowledge in engineering, biology and medicine, and improves human health through cross-disciplinary activities that integrate the engineering sciences with the biomedical sciences and clinical practice.”
Sebastian Hielm: Antimicrobial resistance (AMR) and global health THL
Mr. Sebastian Hielm, Director of Food Safety, Ministry of Agriculture and Forestry, Finland, at One Health Security Conference, 14-15 Oct 2019, THL, Helsinki
One Health – an interdisciplinary approach in combating emerging diseasesILRI
Presentation by Hung Nguyen-Viet, Delia Grace and Jakob Zinsstag at the International Symposium of Health Sciences (iSIHAT 2013), Kuala Lumpur, Malaysia, 20-21 August 2013.
Dr. Laura Kahn - One Health and The Politics of Antimicrobial ResistanceJohn Blue
One Health and The Politics of Antimicrobial Resistance - Dr. Laura Kahn, Research Scholar, Princeton University, from the 2017 NIAA Antibiotic Symposium - Antibiotic Stewardship: Collaborative Strategy for Animal Agriculture and Human Health, October 31 - November 2, 2017, Herndon, Virginia, USA.
More presentations at http://www.swinecast.com/2017-niaa-antibiotic-symposium-antibiotic-stewardship
GRF One Health Summit 2012, Davos: Presentation by Dr. Berhe Tekola - Director - Animal Production and Health - Food and Agriculture Organization of the United Nations FAO
Presented by Hung Nguyen-Viet and Jakob Zinsstag at a technical workshop of the Food and Agriculture Organization of the United Nations (FAO) regional initiative on One Health, Bangkok, Thailand, 11–13 October 2017.
The context surrounding the emergence of infectious diseases and the need to ...ILRI
Presentation by Hung Nguyen-Viet at a Preventing Zoonotic Disease Emergence (PREZODE) side event at the Food and Agriculture Organization of the United Nations (FAO) Forum on Science and Innovation, 13 October 2022.
6th International Disaster and Risk Conference IDRC 2016 Integrative Risk Management - Towards Resilient Cities. 28 August - 01 September 2016 in Davos, Switzerland
Disaster risk reduction and nursing - human science research the view of surv...Global Risk Forum GRFDavos
6th International Disaster and Risk Conference IDRC 2016 Integrative Risk Management - Towards Resilient Cities. 28 August - 01 September 2016 in Davos, Switzerland
Global alliance of disaster research institutes (GADRI) discussion session, A...Global Risk Forum GRFDavos
6th International Disaster and Risk Conference IDRC 2016 Integrative Risk Management - Towards Resilient Cities. 28 August - 01 September 2016 in Davos, Switzerland
Towards a safe, secure and sustainable energy supply the role of resilience i...Global Risk Forum GRFDavos
6th International Disaster and Risk Conference IDRC 2016 Integrative Risk Management - Towards Resilient Cities. 28 August - 01 September 2016 in Davos, Switzerland
Making Hard Choices An Analysis of Settlement Choices and Willingness to Retu...Global Risk Forum GRFDavos
6th International Disaster and Risk Conference IDRC 2016 Integrative Risk Management - Towards Resilient Cities. 28 August - 01 September 2016 in Davos, Switzerland
The Relocation Challenges in Coastal Urban Centers Options and Limitations, A...Global Risk Forum GRFDavos
6th International Disaster and Risk Conference IDRC 2016 Integrative Risk Management - Towards Resilient Cities. 28 August - 01 September 2016 in Davos, Switzerland
6th International Disaster and Risk Conference IDRC 2016 Integrative Risk Management - Towards Resilient Cities. 28 August - 01 September 2016 in Davos, Switzerland
Involving the Mining Sector in Achieving Land Degradation Neutrality, Simone ...Global Risk Forum GRFDavos
6th International Disaster and Risk Conference IDRC 2016 Integrative Risk Management - Towards Resilient Cities. 28 August - 01 September 2016 in Davos, Switzerland
Disaster Risk Reduction and Nursing - Human Science research the view of surv...Global Risk Forum GRFDavos
6th International Disaster and Risk Conference IDRC 2016 Integrative Risk Management - Towards Resilient Cities. 28 August - 01 September 2016 in Davos, Switzerland
Training and awareness raising in Critical Infrastructure Protection & Resili...Global Risk Forum GRFDavos
6th International Disaster and Risk Conference IDRC 2016 Integrative Risk Management - Towards Resilient Cities. 28 August - 01 September 2016 in Davos, Switzerland
IDRC Davos 2016 - Workshop Awareness Raising, Education and Training - Capaci...Global Risk Forum GRFDavos
6th International Disaster and Risk Conference IDRC 2016 Integrative Risk Management - Towards Resilient Cities. 28 August - 01 September 2016 in Davos, Switzerland
6th International Disaster and Risk Conference IDRC 2016 Integrative Risk Management - Towards Resilient Cities. 28 August - 01 September 2016 in Davos, Switzerland
6th International Disaster and Risk Conference IDRC 2016 Integrative Risk Management - Towards Resilient Cities. 28 August - 01 September 2016 in Davos, Switzerland
Dynamic factors influencing the post-disaster resettlement success Lessons fr...Global Risk Forum GRFDavos
6th International Disaster and Risk Conference IDRC 2016 Integrative Risk Management - Towards Resilient Cities. 28 August - 01 September 2016 in Davos, Switzerland
Consequences of the Armed Conflict as a Stressor of Climate Change in Colombi...Global Risk Forum GRFDavos
6th International Disaster and Risk Conference IDRC 2016 Integrative Risk Management - Towards Resilient Cities. 28 August - 01 September 2016 in Davos, Switzerland
Disaster Risk Perception in Cameroon and its Implications for the Rehabilitat...Global Risk Forum GRFDavos
6th International Disaster and Risk Conference IDRC 2016 Integrative Risk Management - Towards Resilient Cities. 28 August - 01 September 2016 in Davos, Switzerland
Systematic Knowledge Sharing of Natural Hazard Damages in Public-private Part...Global Risk Forum GRFDavos
6th International Disaster and Risk Conference IDRC 2016 Integrative Risk Management - Towards Resilient Cities. 28 August - 01 September 2016 in Davos, Switzerland
Exploring the Effectiveness of Humanitarian NGO-Private Sector Collaborations...Global Risk Forum GRFDavos
6th International Disaster and Risk Conference IDRC 2016 Integrative Risk Management - Towards Resilient Cities. 28 August - 01 September 2016 in Davos, Switzerland
Can UK Water Service Providers Manage Risk and Resilience as Part of a Multi-...Global Risk Forum GRFDavos
6th International Disaster and Risk Conference IDRC 2016 Integrative Risk Management - Towards Resilient Cities. 28 August - 01 September 2016 in Davos, Switzerland
A Holistic Approach Towards International Disaster Resilient Architecture by ...Global Risk Forum GRFDavos
6th International Disaster and Risk Conference IDRC 2016 Integrative Risk Management - Towards Resilient Cities. 28 August - 01 September 2016 in Davos, Switzerland
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound